Indication: Pancreatic Adenocarcinoma
A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife® System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
Sub-indication: Pancreatic Adenocarcinoma
Principal Investigator: Robert Martin, M.D., Ph.D.University of Louisville Physicians - Surgical Oncology
Sponsor: AngioDynamics, Inc.
Email for more information: email@example.com